FDA Consents to Phase I Trials of HEMO-CAR-T LONDON, UK / ACCESSWIRE / February 9, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has been informed by the U.S. Federal Food and Drug Administration ("FDA") that it has lifted the clinical hold on the Investigational New Drug (IND) application for HEMO-CAR-T for the treatment of acute myeloid leukemia ("AML"). The FDA confirmed that the Company had addressed all issues identified in its prior clinical hold letter
The global clinical trials market was estimated to be worth $38.7 billion in 2021 and is expected to reach £52 billion by 2026. In this article, we look at the top 12 CROs in the world, highlighting the companies driving this considerable growth and accelerating research and development across the globe .
HUTCHMED (China) Limited (HCM) Just Got Our Attention newsheater.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsheater.com Daily Mail and Mail on Sunday newspapers.
Investegate |Hutchmed China Ltd Announcements | Hutchmed China Ltd: HUTCHMED Initiates Phase I Trials of HMPL-295 investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.